Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 9—September 2019
Research Letter

Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients

Anne-Pauline BellangerComments to Author , Ana Berceanu, Emeline Scherer, Yohan Desbrosses, Etienne Daguindau, Steffi Rocchi, and Laurence Millon
Author affiliations: University Hospital, Besançon, France (A.-P. Bellanger, E. Scherer, S. Rocchi, L. Millon); Franche-Comté University, Besançon (A.-P. Bellanger, E. Scherer, L. Millon); Besançon University Hospital, Besançon (A. Berceanu, Y. Desbrosses, E. Daguindau)

Main Article

Figure

Evolution of fungal biomarkers, computed tomography chest scans, and antifungal treatments for immunocompromised patient 1 with invasive Aspergillus fumigatus infection, France, 2018. Arrows indicate lesions. qPCR, quantitative PCR.

Figure. Evolution of fungal biomarkers, computed tomography chest scans, and antifungal treatments for immunocompromised patient 1 with invasive Aspergillus fumigatus infection, France, 2018. Arrows indicate lesions. qPCR, quantitative PCR.

Main Article

Page created: August 21, 2019
Page updated: August 21, 2019
Page reviewed: August 21, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external